1.
Can Assoc Radiol J
; 75(3): 593-600, 2024 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38420877
RESUMO
Breast cancer screening guidelines vary for women at intermediate risk (15%-20% lifetime risk) for developing breast cancer across jurisdictions. Currently available risk assessment models have differing strengths and weaknesses, creating difficulty and ambiguity in selecting the most appropriate model to utilize. Clarifying which model to utilize in individual circumstances may help determine the best screening guidelines to use for each individual.